As of close of business last night, Privia Health Group Inc’s stock clocked out at $17.69, down -3.60% from its previous closing price of $18.35. On the day, 1000129 shares were traded.
Ratios:
To gain a deeper understanding of PRVA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.00. For the most recent quarter (mrq), Quick Ratio is recorded 1.81 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $22.
BofA Securities Downgraded its Buy to Neutral on February 22, 2024, while the target price for the stock was maintained at $21.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 02 ’24 when Mountcastle David sold 3,933 shares for $17.77 per share. The transaction valued at 69,889 led to the insider holds 262,279 shares of the business.
Sullivan William M sold 400 shares of PRVA for $9,208 on Mar 11 ’24. The Director now owns 5,445,018 shares after completing the transaction at $23.02 per share. On Mar 08 ’24, another insider, Sullivan William M, who serves as the Director of the company, sold 7,115 shares for $23.03 each. As a result, the insider received 163,858 and left with 5,445,418 shares of the company.
Valuation Measures:
As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 95.52, and their Forward P/E ratio for the next fiscal year is 53.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.27 while its Price-to-Book (P/B) ratio in mrq is 3.72.
Stock Price History:
Over the past 52 weeks, PRVA has reached a high of $30.15, while it has fallen to a 52-week low of $17.54.
Shares Statistics:
A total of 118.22M shares are outstanding, with a floating share count of 101.89M. Insiders hold about 14.06% of the company’s shares, while institutions hold 95.84% stake in the company.
Earnings Estimates
As of right now, Prothena Corporation plc analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $20.40, with high estimates of $17.69 and low estimates of $22.31.
